Synopsis
0
KDMF
0
VMF
0
Canada
0
South Africa
DRUG PRODUCT COMPOSITIONS0
Data Compilation #PharmaFlow
0
Weekly News Recap #Phispers
API SUPPLIERS
Veranova: A CDMO that manages complexity with confidence.
Click Us!
JDMF
NDC
Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.
EU-WC
EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
CEP/COS
ASMF
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - FILM;SUBLINGUAL - 10MG
USFDA APPLICATION NUMBER - 210875
DOSAGE - FILM;SUBLINGUAL - 15MG
USFDA APPLICATION NUMBER - 210875
DOSAGE - FILM;SUBLINGUAL - 20MG
USFDA APPLICATION NUMBER - 210875
DOSAGE - FILM;SUBLINGUAL - 25MG
USFDA APPLICATION NUMBER - 210875
DOSAGE - FILM;SUBLINGUAL - 30MG
USFDA APPLICATION NUMBER - 210875
DOSAGE - INJECTABLE;SUBCUTANEOUS - 30MG/3ML (...DOSAGE - INJECTABLE;SUBCUTANEOUS - 30MG/3ML (10MG/ML)
USFDA APPLICATION NUMBER - 21264
Digital Content
STOCK RECAP #PipelineProspector
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
32
PharmaCompass offers a list of Apomorphine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Apomorphine Hydrochloride manufacturer or Apomorphine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Apomorphine Hydrochloride manufacturer or Apomorphine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Apomorphine Hydrochloride API Price utilized in the formulation of products. Apomorphine Hydrochloride API Price is not always fixed or binding as the Apomorphine Hydrochloride Price is obtained through a variety of data sources. The Apomorphine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Apomorphinum hydrochloricum manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Apomorphinum hydrochloricum, including repackagers and relabelers. The FDA regulates Apomorphinum hydrochloricum manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Apomorphinum hydrochloricum API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Apomorphinum hydrochloricum manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Apomorphinum hydrochloricum supplier is an individual or a company that provides Apomorphinum hydrochloricum active pharmaceutical ingredient (API) or Apomorphinum hydrochloricum finished formulations upon request. The Apomorphinum hydrochloricum suppliers may include Apomorphinum hydrochloricum API manufacturers, exporters, distributors and traders.
click here to find a list of Apomorphinum hydrochloricum suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Apomorphinum hydrochloricum DMF (Drug Master File) is a document detailing the whole manufacturing process of Apomorphinum hydrochloricum active pharmaceutical ingredient (API) in detail. Different forms of Apomorphinum hydrochloricum DMFs exist exist since differing nations have different regulations, such as Apomorphinum hydrochloricum USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Apomorphinum hydrochloricum DMF submitted to regulatory agencies in the US is known as a USDMF. Apomorphinum hydrochloricum USDMF includes data on Apomorphinum hydrochloricum's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Apomorphinum hydrochloricum USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Apomorphinum hydrochloricum suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Apomorphinum hydrochloricum Drug Master File in Japan (Apomorphinum hydrochloricum JDMF) empowers Apomorphinum hydrochloricum API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Apomorphinum hydrochloricum JDMF during the approval evaluation for pharmaceutical products. At the time of Apomorphinum hydrochloricum JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Apomorphinum hydrochloricum suppliers with JDMF on PharmaCompass.
A Apomorphinum hydrochloricum CEP of the European Pharmacopoeia monograph is often referred to as a Apomorphinum hydrochloricum Certificate of Suitability (COS). The purpose of a Apomorphinum hydrochloricum CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Apomorphinum hydrochloricum EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Apomorphinum hydrochloricum to their clients by showing that a Apomorphinum hydrochloricum CEP has been issued for it. The manufacturer submits a Apomorphinum hydrochloricum CEP (COS) as part of the market authorization procedure, and it takes on the role of a Apomorphinum hydrochloricum CEP holder for the record. Additionally, the data presented in the Apomorphinum hydrochloricum CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Apomorphinum hydrochloricum DMF.
A Apomorphinum hydrochloricum CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Apomorphinum hydrochloricum CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Apomorphinum hydrochloricum suppliers with CEP (COS) on PharmaCompass.
A Apomorphinum hydrochloricum written confirmation (Apomorphinum hydrochloricum WC) is an official document issued by a regulatory agency to a Apomorphinum hydrochloricum manufacturer, verifying that the manufacturing facility of a Apomorphinum hydrochloricum active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Apomorphinum hydrochloricum APIs or Apomorphinum hydrochloricum finished pharmaceutical products to another nation, regulatory agencies frequently require a Apomorphinum hydrochloricum WC (written confirmation) as part of the regulatory process.
click here to find a list of Apomorphinum hydrochloricum suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Apomorphinum hydrochloricum as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Apomorphinum hydrochloricum API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Apomorphinum hydrochloricum as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Apomorphinum hydrochloricum and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Apomorphinum hydrochloricum NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Apomorphinum hydrochloricum suppliers with NDC on PharmaCompass.
Apomorphinum hydrochloricum Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Apomorphinum hydrochloricum GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Apomorphinum hydrochloricum GMP manufacturer or Apomorphinum hydrochloricum GMP API supplier for your needs.
A Apomorphinum hydrochloricum CoA (Certificate of Analysis) is a formal document that attests to Apomorphinum hydrochloricum's compliance with Apomorphinum hydrochloricum specifications and serves as a tool for batch-level quality control.
Apomorphinum hydrochloricum CoA mostly includes findings from lab analyses of a specific batch. For each Apomorphinum hydrochloricum CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Apomorphinum hydrochloricum may be tested according to a variety of international standards, such as European Pharmacopoeia (Apomorphinum hydrochloricum EP), Apomorphinum hydrochloricum JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Apomorphinum hydrochloricum USP).
